Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 8/20 | 0.72 |
| ▸ | GAA | P10253 | 5/20 | 0.72 |
| ▸ | MGAM | O43451 | 4/20 | 0.61 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.57 |
| ▸ | UGCG | Q16739 | 2/20 | 0.54 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2265347 | 1.00 | GBA1 (0.72) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL6135325 | 1.00 | GBA1 (0.72) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL2433104 | 1.00 | GBA1 (0.72) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL2268885 | 1.00 | GBA1 (0.72) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL7911357 | 1.00 | GBA1 (0.72) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL7908086 | 0.95 | MGAM (0.68) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL2266205 | 0.95 | MGAM (0.68) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL7911388 | 0.95 | MGAM (0.68) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL7911362 | 0.95 | MGAM (0.68) | GBA1GAAMGAMFUCA1UGCG | |
| SCHEMBL2435939 | 0.95 | MGAM (0.68) | GBA1GAAMGAMFUCA1UGCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0624652-B1 | Process for producing N-substituted polyhydroxy nitrogen-containing heterocycles | MONSANTO CO (US) | 2001-10-10 | — | — | EP | disclosed |
| US-5695969-A | Process for producing N-substituted polyhydroxy nitrogen-containing heterocycles | MONSANTO COMPANY (US) | 1997-12-09 | — | — | US | disclosed |
| US-5401645-A | Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles utilizing acetobacteraceae and corynebacterium | MONSANTO COMPANY (US) | 1995-03-28 | — | — | US | disclosed |
| EP-0624652-A1 | Process for producing N-substituted polyhydroxy nitrogen-containing heterocycles | MONSANTO COMPANY (US) | 1994-11-17 | — | — | EP | disclosed |
| EP-0322395-B1 | HETEROCYCLIC COMPOUNDS FOR INHIBITING VIRUS | Monsanto Company (US) | 1993-03-24 | — | — | EP | disclosed |
| US-5089520-A | Administering 1,4-dideoxy-1,4-imino-L-arabinitol or 1,4-dideoxy-1,4-imino-D-ribitol; human immunodeficiency virus | MONSANTO COMPANY (US) | 1992-02-18 | — | — | US | disclosed |
| US-5043416-A | Method of inhibiting virus | MONSANTO COMPANY (US) | 1991-08-27 | — | — | US | disclosed |
| US-4999360-A | Treatment of AIDS, polyhydroxy piperidine derivatives | MONSANTO COMPANY (US) | 1991-03-12 | — | — | US | disclosed |
| EP-0322395-A1 | Heterocyclic compounds for inhibiting virus | Monsanto Company (US) | 1989-06-28 | — | — | EP | disclosed |